MR spectroscopy of the brain in Leigh syndrome

Brain and Development

Volumn 30, Issue 9, 2008, Pages 579-583

  Sijens, P E ^a   Smit, G P A ^b   Rodiger L A ^a   van Spronsen, F J ^b   Oudkerk, M ^a   Rodenburg, R J ^c   Lunsing, R J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Leigh syndrome; Magnetic resonance spectroscopy; Mitochondrial diseases

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; LACTIC ACID; N ACETYLASPARTIC ACID;

ARTICLE; BRAIN TISSUE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GRAY MATTER; HUMAN; IMAGING SYSTEM; LACTATE BLOOD LEVEL; LEIGH DISEASE; MALE; MUSCLE BIOPSY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

BRAIN; CHOLINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT; KEARNS-SAYER SYNDROME; LACTATES; LEIGH DISEASE; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 49749116812     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2008.01.011     Document Type: Article

References (15)

1. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14 (1951) 216-221
2. Fujii T., Ito M., Okuno T., Mutoh K., Nishikomori R., and Mikawa H. Complex I (reduced nicotinamide-adenine dinucleotide-coenzyme Q reductase) deficiency in two patients with probable Leigh syndrome. J Pediatr 116 (1990) 84-87
3. Krägeloh-Mann I., Grodd W., Schöning M., Marquard K., Nägele T., and Ruitenbeek W. Proton spectroscopy in five patients with Leigh's disease and mitochondrial enzyme deficiency. Dev Med Child Neurol 35 (1993) 769-776
4. 1H magnetic resonance spectroscopy. Ann Neurol 29 (1991) 218-221
5. Takahashi S., Oki J., Miyamoto A., and Okuno A. Proton magnetic resonance spectroscopy to study the metabolic changes in the brain of a patient with Leigh syndrome. Brain Dev 21 (1999) 200-204
6. Takanashi J., Sugita K., Tanabe Y., Maemoto T., and Niimi H. Dichloroacetate treatment in Leigh syndrome caused by mitochondrial DNA mutation. J Neurol Sci 145 (1997) 83-86
7. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 37 (1997) 222-225
8. 1H chemical shift imaging of the human brain at age 60-90 years reveals metabolic differences between women and men. Magn Reson Med 42 (1999) 24-31
9. Padma M.V., Adineh M., Pugar K., Mukherjee J., Satter M., Shi B., et al. Functional imaging of a large demyelinating lesion. J Clin Neurosci 12 (2005) 176-178
10. Arii J., and Tanabe Y. Leigh syndrome: serial MR imaging and clinical follow-up. AJNR Am J Neuroradiol 21 (2000) 1502-1509
11. Stefano N.D., Narayanan S., Matthews P.M., Mortilla M., Dotti M.T., Federico A., et al. Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders. J Neurovirol 6 Suppl. 2 (2000) S121-S129
12. 1H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings. Eur Radiol 16 (2006) 489-495
13. Bianchi M.C., Tosetti M., Battini R., Manca M.L., Mancuso M., Cioni G., et al. Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance. AJNR Am J Neuroradiol 24 (2003) 1958-1966
14. Heidenreich J.O., Klopstock T., Schirmer T., Saemann P., Müller-Felber W., and Auer D.P. Chronic progressive external ophthalmoplegia: MR spectroscopy and MR diffusion studies in the brain. AJR Am J Roentgenol 187 (2006) 820-824
15. Möller H.E., Kurlemann G., Pützler M., Wiedermann D., Hilbich T., and Fiedler B. Magnetic resonance spectroscopy in patients with MELAS. J Neurol Sci 229-230 (2005) 131-139